Startek’s subsidiary refinances $185 million debt
February 25, 2021
×
CSP Alpha Holdings Pte Ltd, a wholly-owned subsidiary of Startek, has completed refinancing of a newly-secured $185 million debt facility, comprising a $165-million term loan and a $20-million revolving credit facility.
Borrowings under the new senior debt will bear a tiered interest rate, which is based on the company’s consolidated net leverage ratio and is initially set at LIBOR plus 450 basis points, the company said in a statement.
ALSO READ
“Our new credit facility allows us to extend the maturities of our debt and provides enhanced liquidity. Most importantly, it has a moratorium on principal repayments for the first 21 months, which will provide increased flexibility for the company to manage its operations and finances. This also enables us to take advantage of growth opportunities and long-term strategic investments that can further improve the margin profile and earnings power of the organ
Read more about Startek announces $185mn debt refinancing with term loan, revolving credit on Business Standard. Borrowings under new senior debt will bear tiered interest rate, based on Startek s consolidated net leverage ratio and is initially set at Libor plus 450 bps
Startek Announces $185 Million Debt Refinancing
Thursday, February 25, 2021 8:35PM IST (3:05PM GMT)
New Senior Debt Extends Maturity to February 2026
Greenwood Village, Colo., United States:
Startek, Inc. (NYSE: SRT) ( Startek or the Company ), a global provider of customer experience management solutions, today announced that CSP Alpha Holdings Pte. Ltd., a wholly-owned subsidiary of the Company, has successfully completed a debt refinancing with a newly secured $185 million senior debt facility, comprising a $165 million term loan and a $20 million revolving credit facility. Borrowings under the new senior debt will bear a tiered interest rate, which is based on the Company’s consolidated net leverage ratio and is initially set at LIBOR plus 450 basis points.
GenesisCare and PreludeDx™ Partner to Provide Access to Ground-Breaking Precision Medicine Test for Women With Early-Stage Breast Cancer
on February 23 2021 9:00 PM
SYDNEY & LAGUNA HILLS, Calif. (BUSINESS WIRE) #breastcancerawareness GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx
TM), a leader in molecular diagnostics and precision medicine, today announced a new strategic partnership aimed at increasing access to personalized breast cancer treatment and improved patient outcomes.
DCISionRT
® is a precision medicine test for women diagnosed with DCIS (Ductal Carcinoma in situ) or Stage 0 breast cancer who are treated with breast-conserving surgery. The DCISionRT test, developed by PreludeDx, assesses a woman’s 10-year risk of recurrence of DCIS or development of invasive breast cancer. The test provides predictive information regarding recurrence risk, allowing physicians to better select those patients who will benefi
FTI Consulting Expands RelativityOne Offering to Canada USA/Canada News Editor
FTI Consulting, Inc today announced the Company’s Technology segment has expanded its partnership with Relativity to provide its cloud-based e-discovery solution RelativityOne in Canada.
In Canada, organizations are facing myriad new e-discovery challenges, particularly around Canadian Competition Bureau investigations and complex supplementary information requests in the merger clearance process. As part of the Competition Bureau’s efforts to increase antitrust oversight in the digital age, it recently announced a cooperation framework with the U.S., UK, Australia and New Zealand, further raising the regulatory stakes for multinational companies seeking M&A approvals in those countries. Experts expect this to lead to an uptick in the volume, cost and complexity of conducting e-discovery in response to global merger investigations.